A Cambridge-Belgium technology collaboration has created a device which helps people whose speech has been impaired by crippling conditions to find their voice.

The University of Cambridge and University College London (UCL) will share in a £50 million bonus haul from the UK government designed to unearth new technology and encourage entrepreneurship to advance medical innovation.

Medical technology business Vectura, which has research operations in Cambridge UK, has launched a major push in Asia by establishing a joint venture with Chinese and Hong Kong partners.

The crucial first hours of an embryo can now be captured for the first time by new imaging technology being pioneered at the Bourn Hall Clinic in Cambridge UK – boosting the success chances of IVF, according to experts.

Cambridge medical technology business, GW Pharmaceuticals, has earned a key European approval for its cannabis-based prescription medicine Sativex® in Italy – and a €250k windfall in the process.

Cambridge medical technology business, GW Pharmaceuticals, has earned a key European approval for its cannabis-based prescription medicine Sativex® in Italy – and a €250k windfall in the process.

A Cambridge regenerative medicine business whose technology uses a patient’s own tissue to rebuild breasts after cancer surgery has boosted its capabilities with a UK acquisition.

Pioneering software is being developed in Cambridge UK to deliver personalised radiotherapy treatment to individual cancer patients.

GW Pharmaceuticals, the Cambridge UK biopharma business whose products are developed from cannabis, has made a bullish bow on the US technology market NASDAQ – raising $31.2 million in an over-subscribed IPO.

A range of diseases and conditions – from asthma to liver disease – could be diagnosed and monitored quickly and painlessly just by breathing, using gas sensing technology developed by a Cambridge UK spin-out business.

Another significant cash award from the UK Government has flagged up the importance of the biomedical technology cluster in Cambridge – especially in cancer research.

UK technology hothouse Cambridge Consultants has helped US drug development world leader Catalent validate a $20 million investment in inhalation drug development and supply facilities.

Cambridge UK personalised medicines pioneer Horizon Discovery has landed a $100 million blockbuster deal with global pharma giant AstraZeneca.

Cambridge-based BiomedTech business Kymab has gained further commercial traction after selling its mouse-based antibody technology to global pharma company Novo Nordisk.

A cancer spray delivering a cannabis-based medicine – developed by a Cambridge UK medical technology business – has won a key patent approval in the US.

Healthcare technology specialist Cambridge Cognition Holdings raised £6.4 million on its AIM IPO as the shares made their UK bow today at a placing price of 70p.

The Centre for Entrepreneurial Learning (CfEL) at Cambridge Judge Business School has teamed up with Doctorpreneurs.com, as well as a host of industry leaders and design experts, to create a fantastic opportunity to explore and develop digital health technology.